TTRX
Turn Therapeutics Inc.
Key Financials
Net Income
$-3194080
↓ 80.6%
Operating Income
$-5858648
↓ 226.0%
Total Assets
$12.2M
↑ 493.6%
Total Liabilities
$7.5M
↑ 235.8%
Cash & Equivalents
$4.0M
↑ 708.3%
EPS (Diluted)
$-0.12
↓ 71.4%
Long-term Debt
$7.3M
N/A
Shareholders' Equity
$4.7M
↑ 2741.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/19/2026 | View on SEC |
| 8-K | 5/18/2026 | View on SEC |
| C-TR | 5/13/2026 | View on SEC |
| 10-Q | 5/11/2026 | View on SEC |
| 8-K | 5/11/2026 | View on SEC |
| SCHEDULE 13G | 4/6/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TTRX |
| Company Name | Turn Therapeutics Inc. |
| CIK | 2023016 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 8185644011 |